Executive Profile*

Phillip A. Sharp Ph.D.

AgeTotal Calculated CompensationThis person is connected to 174 board members in 10 different organizations across 9 different industries.

See Board Relationships
71$948,385

Background*

Dr. Phillip A. Sharp, also known as Phil, Ph.D., Co-Founded Alnylam Pharmaceuticals, Inc. in 2002. Dr. Sharp serves as the President of American Association for the Advancement of Science. He Co-founded Biogen Idec Inc. in 1978. He co-founded Magen BioSciences, Inc. (now known as PPD Dermatology, Inc.) in 2006. He serves as the Chairman of Scientific Advisory Board of Fidelity Biosciences. He served as Co-Chairman of Scientific Strategy and Advisory Group of Alnylam ...

Read Full Background

Corporate Headquarters*

1200 New York Avenue NW
Washington, District Of Columbia 20005

United States

Phone: 202-326-6400
Fax: --

Board Members Memberships*

Director
Director
Director and Member of Strategic Advisory Board
2002-Present
Co-Founder, Director and Member of the Scientific Advisory Board
2012-Present
Director, Member of Scientific Advisory Board and Chairman of Compensation Committee

Education*

PhD
University of Illinois-Urbana-Champaign
BA
Union College

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

Total Annual Cash Compensation$90,000
Total Calculated Compensation$948,385
*Data is at least as current as the most recent Definitive Proxy.
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Stanley T. Crooke M.D., Ph.D.Founder, Executive Chairman, Chief Executive Officer and President
Ionis Pharmaceuticals, Inc.
$1.5M
Edward M. Kaye M.D., Ph.D.Chief Executive Officer, President, Chief Medical Officer and Director
Sarepta Therapeutics, Inc.
$494.6K
Mark Joseph Murray Ph.D.Chief Executive Officer, President and Executive Director
Arbutus Biopharma Corporation
$954.9K
Paul C. Grint M.D.Chief Executive Officer, President and Director
Regulus Therapeutics Inc.
$446.5K
Douglas M. Fambrough III, Ph.D.Co-Founder, Chief Executive Officer, President and Director
Dicerna Pharmaceuticals, Inc.
$490.0K
Compensation as of Fiscal Year 2015.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact , please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.